The Race to Bring Back the Dodo: Colossal Biosciences' Ambitious Mission
Colossal Biosciences, a Dallas-based startup, claims it can resurrect extinct species like the dodo. Critics debate the ethics, but the company says it's a moral obligation. Explore the controversy surrounding de-extinction technology.
Colossal Biosciences, a Dallas-based startup, has provoked both acclaim and denunciation with its ambitious goal of resurrecting extinct animal species, including the iconic dodo. The company, valued at $10.2 billion, has secured hundreds of millions in funding from high-profile investors, raising weighty questions about the ethics and feasibility of "de-extinction" technology.
CEO Ben Lamm asserts that Colossal's work follows a "moral obligation" to restore species lost to human activity. However, critics argue that it's merely "tech bro" hype that could undermine conservation efforts. The debate surrounding Colossal's plans highlights the complexities of reviving species that have been extinct for thousands of years.
